Dennis D. Weisenburger
#111,440
Most Influential Person Now
Dennis D. Weisenburger's AcademicInfluence.com Rankings
Dennis D. Weisenburgerphilosophy Degrees
Philosophy
#4691
World Rank
#7305
Historical Rank
Logic
#2100
World Rank
#3012
Historical Rank
Dennis D. Weisenburgerbiology Degrees
Biology
#6193
World Rank
#8858
Historical Rank
Molecular Biology
#621
World Rank
#636
Historical Rank
Download Badge
Philosophy Biology
Dennis D. Weisenburger's Degrees
- PhD Molecular Biology Stanford University
- Doctorate Medicine Stanford University
Why Is Dennis D. Weisenburger Influential?
(Suggest an Edit or Addition)Dennis D. Weisenburger's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (2000) (9767)
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. (2004) (3681)
- The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. (2002) (2370)
- International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. (2008) (1692)
- A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project (1997) (1664)
- Stromal gene signatures in large-B-cell lymphomas. (2008) (1611)
- Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. (2006) (1544)
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma (2010) (1436)
- Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. (2004) (1410)
- Oncogenically active MYD88 mutations in human lymphoma (2011) (1341)
- New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. (1998) (1271)
- Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. (2010) (1140)
- Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma (2003) (1074)
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways (2008) (971)
- The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. (2003) (948)
- Molecular diagnosis of Burkitt's lymphoma. (2006) (871)
- Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (2012) (844)
- Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (766)
- Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. (1998) (666)
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. (2009) (643)
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy (2009) (625)
- ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. (2008) (612)
- Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. (1999) (537)
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. (2014) (510)
- Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. (2011) (456)
- Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. (2002) (422)
- Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. (1988) (411)
- Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32) (1999) (400)
- Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. (2005) (400)
- Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia (2007) (391)
- Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. (2012) (386)
- Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. (1985) (372)
- Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). (2007) (366)
- Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. (2011) (358)
- Mantle cell lymphoma-- an entity comes of age. (1996) (357)
- SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype (2009) (356)
- Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. (2010) (350)
- Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. (2015) (350)
- A Case‐Control Study of Non‐Hodgkin's Lymphoma and the Herbicide 2,4‐Dichlorophenoxyacetic Acid (2, 4‐D) in Eastern Nebraska (1990) (345)
- Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma. (2016) (336)
- Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. (2005) (335)
- Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. (2008) (318)
- p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. (1996) (308)
- The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. (2002) (305)
- Drinking Water Nitrate and the Risk of Non‐Hodgkin's Lymphoma (1996) (298)
- Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. (2011) (293)
- Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. (2013) (288)
- BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. (2004) (284)
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (280)
- Mantle‐zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma (1982) (279)
- Integrative assessment of multiple pesticides as risk factors for non-Hodgkin’s lymphoma among men (2003) (277)
- Cooperative epigenetic modulation by cancer amplicon genes. (2010) (273)
- The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. (1999) (272)
- Dietary patterns and adenocarcinoma of the esophagus and distal stomach. (2002) (259)
- The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. (1988) (254)
- Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. (2007) (243)
- Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases (1981) (238)
- BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. (2006) (231)
- Loss of signaling via Gα13 in germinal center B cell-derived lymphoma (2014) (226)
- Differences in incidence and trends of haematological malignancies in Japan and the United States (2013) (222)
- InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. (2010) (210)
- Human health effects of agrichemical use. (1993) (205)
- Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma (2007) (200)
- Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. (1986) (197)
- Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic. (1994) (187)
- High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma (1989) (185)
- Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. (2007) (183)
- Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. (1999) (182)
- The clinical spectrum of Castleman's disease (2012) (180)
- Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. (2007) (178)
- Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. (1990) (178)
- MYC and BCL2 protein expression predicts survival in patients with diffuse large B‐cell lymphoma treated with rituximab (2014) (175)
- Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). (2006) (172)
- Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. (1986) (171)
- Nutrient Intakes and Adenocarcinoma of the Esophagus and Distal Stomach (2002) (171)
- IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. (2014) (170)
- BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab (2011) (170)
- Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. (2006) (169)
- Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. (1999) (169)
- Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries (2003) (168)
- Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. (1995) (167)
- An update of the epidemiology of non-Hodgkin's lymphoma. (2003) (166)
- Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms (2007) (165)
- High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. (1989) (162)
- Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. (1992) (158)
- Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group (2000) (158)
- Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. (1989) (154)
- Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA) (2016) (151)
- A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. (2003) (150)
- Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma (2006) (150)
- Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. (2013) (149)
- Clonality in nodular lymphocyte-predominant Hodgkin's disease. (1997) (146)
- Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. (1995) (144)
- Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. (1996) (142)
- Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma (2014) (140)
- The Genetic Basis of Hepatosplenic T-cell Lymphoma. (2017) (140)
- Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. (2010) (139)
- Agricultural use of organophosphate pesticides and the risk of non-Hodgkin's lymphoma among male farmers (United States) (2001) (137)
- Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. (2019) (135)
- Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. (1987) (134)
- Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (131)
- Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro (2011) (130)
- Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with "Hodgkin's transformation". (1998) (130)
- Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project. (1997) (130)
- Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. (2017) (129)
- The role of agricultural pesticide use in the development of non-Hodgkin's lymphoma in women. (1993) (127)
- Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. (1992) (126)
- Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. (2014) (125)
- Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. (1992) (122)
- Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma (2005) (121)
- Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases. (2012) (119)
- Cutaneous &ggr;&dgr; T-cell Lymphomas: A Spectrum of Presentations With Overlap With Other Cytotoxic Lymphomas (2012) (118)
- Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. (1994) (118)
- Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. (2013) (117)
- Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site (2014) (117)
- Detection and clinical significance of minimal tumor cell contamination of peripheral stem call harvests (1992) (116)
- Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project (2016) (115)
- Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. (2014) (114)
- High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy (2011) (111)
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. (2015) (110)
- Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. (2007) (110)
- Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States) (1994) (109)
- Hedgehog-Induced Survival of B-Cell Chronic Lymphocytic Leukemia Cells in a Stromal Cell Microenvironment: A Potential New Therapeutic Target (2008) (108)
- Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma (2003) (108)
- Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. (1989) (107)
- Non‐Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium (2007) (106)
- Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis (2007) (105)
- Recurrent activating mutations of CD28 in peripheral T-cell lymphomas (2016) (103)
- Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. (1991) (102)
- Malignant lymphoma in the X‐linked lymphoproliferative syndrome (1987) (102)
- Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. (2012) (101)
- Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. (1996) (101)
- The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. (1995) (100)
- Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. (1999) (99)
- Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group. (1990) (98)
- DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status (2008) (98)
- Diet and risk of adult glioma in eastern Nebraska, United States (2002) (98)
- Familial multiple myeloma: a family study and review of the literature. (2001) (97)
- Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. (1989) (97)
- A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. (2006) (96)
- Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. (2006) (96)
- Agricultural pesticide use and risk of glioma in Nebraska, United States (2005) (94)
- Monoclonal antibodies marking T lymphocytes in paraffin-embedded tissue. (1987) (93)
- Lymphomatoid Papulosis: A T-Cell Dyscrasia with a Propensity To Transform into Malignant Lymphoma (1995) (90)
- Chromosomal abnormalities in Hodgkin's disease. (1989) (90)
- Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (89)
- Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. (1995) (89)
- B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and burkitt lymphoma: study of 39 cases (2013) (88)
- Environmental epidemiology of non-Hodgkin's lymphoma in eastern Nebraska. (1990) (87)
- MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. (2013) (86)
- New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies. (2017) (84)
- Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease. (2002) (84)
- Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen. (2002) (83)
- Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases. (2013) (83)
- Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). (1988) (82)
- Mantle zone lymphoma a clinicopathologic study of 22 cases (1990) (82)
- Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma (2008) (81)
- Peripheral T‐cell lymphoma (1989) (80)
- The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab. (2011) (80)
- High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma. (1998) (80)
- Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21). (1988) (80)
- IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans (2015) (78)
- Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. (1995) (77)
- Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma (2016) (77)
- Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt’s lymphoma (2008) (76)
- Occupation and Risk of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia (2002) (76)
- Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions. (2005) (75)
- Similar patterns of genomic alterations characterize primary mediastinal large‐B‐cell lymphoma and diffuse large‐B‐cell lymphoma (2002) (75)
- Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry. (2019) (74)
- Autologous hematopoietic stem cell transplantation for mantle cell lymphoma. (2000) (73)
- Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings (1987) (73)
- Epstein-Barr Virus Negative Clonal Plasma Cell Proliferations and Lymphomas in Peripheral T-cell Lymphomas: A Phenomenon With Distinctive Clinicopathologic Features (2007) (72)
- Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach (2012) (71)
- Intermediate lymphocytic lymphoma: an immunohistologic study with comparison to other lymphocytic lymphomas. (1987) (71)
- Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. (1996) (71)
- MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. (2011) (71)
- Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index. (2008) (70)
- Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience. (2006) (69)
- Central Nervous System Involvement in Patients with Diffuse Aggressive Non‐Hodgkin's Lymphoma (1991) (69)
- Acute renal failure associated with autologous bone marrow transplantation. (1987) (69)
- Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. (1990) (68)
- Cyclin D 1 – negative mantle cell lymphoma : a clinicopathologic study based on gene expression profiling (2005) (67)
- Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. (1991) (67)
- Adenocarcinoma of the Stomach and Esophagus and Drinking Water and Dietary Sources of Nitrate and Nitrite (2008) (66)
- Phenotypic heterogeneity in multiple myeloma families. (2005) (65)
- Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization. (1997) (65)
- Towards understanding the peripheral T-cell lymphomas. (2004) (65)
- The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. (2009) (64)
- Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. (2004) (63)
- X-linked lymphoproliferative disease. (1993) (63)
- Chronic Lymphocytic Leukemia Cells in a Lymph Node Microenvironment Depict Molecular Signature Associated with an Aggressive Disease (2014) (63)
- A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. (2012) (62)
- Immunoblastic lymphadenopathy with pulmonary infiltrates, hypocomplementemia and vasculitis. A hyperimmune syndrome. (1977) (62)
- Adult Burkitt lymphoma: advances in diagnosis and treatment. (2008) (61)
- Mantle‐zone lymphoma. An immunohistologic study (1984) (59)
- Peripheral T‐cell lymphoma: A clinicopathologic study of 42 cases (1987) (59)
- Remission of giant lymph node hyperplasia with anemia after radiotherapy (1979) (58)
- Association of NAT and GST polymorphisms with non‐Hodgkin's lymphoma: a population‐based case–control study (2005) (58)
- Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. (1995) (58)
- Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. (2012) (58)
- Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma (2005) (58)
- Pathological classification of non-Hodgkin's lymphoma for epidemiological studies. (1992) (58)
- Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. (1988) (57)
- Lymphomatoid papulosis and progression to T cell lymphoma: an immunophenotypic and genotypic analysis. (1989) (57)
- Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. (2014) (57)
- CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma. (2019) (57)
- Lymphomatous polyposis. A neoplasm of either follicular mantle or germinal center cell origin. (1996) (55)
- Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin's Lymphoma Classification Project. (1999) (54)
- Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma. A Report of 21 Cases from the Nebraska Lymphoma Study Group (2003) (54)
- Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. (2017) (53)
- Risk of myeloid neoplasms after solid organ transplantation (2014) (53)
- Clinical significance of hematologic parameters in non‐Hodgkin's lymphoma at diagnosis (1991) (53)
- Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation. (1989) (53)
- CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma (2016) (52)
- Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue. (1988) (52)
- Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project (2001) (52)
- Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma. Nebraska Lymphoma Study Group. (1990) (51)
- Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study. (2009) (51)
- Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. (2015) (51)
- Clonality analysis of B‐lymphoid proliferations using the polymerase chain reaction (1996) (50)
- Epstein-Barr Virus Genome in Non-Hodgkin ’ s Lymphomas Occurring in Immunocompetent Patients : Highest Prevalence in Nonlymphoblastic T-cell Lymphoma and Correlation With a Poor Prognosis (2002) (50)
- Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens. (2018) (50)
- Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules. (2013) (49)
- Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling (2015) (48)
- Tobacco and non-Hodgkin's lymphoma: combined analysis of three case-control studies (United States) (1997) (48)
- Diffuse Large B-cell Lymphoma: A Clinicopathologic Analysis of 444 Cases Classified According to the Updated Kiel Classification (2002) (48)
- Peripheral T‐cell lymphoma in childhood and adolescence a clinicopathologic study of 22 patients (1993) (47)
- Fluorescence in situ Hybridization Detection of Cytogenetic Abnormalities in B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (2004) (47)
- Peripheral T-cell lymphoma in children and adolescents: role of bone marrow transplantation. (1994) (46)
- Use of the World Health Organization (WHO) Classification of Non-Hodgkin's Lymphoma in Mumbai, India: A Review of 200 Consecutive Cases by a Panel of Five Expert Hematopathologists (2004) (46)
- t(14;18)-negative Follicular Lymphomas Are Associated with a High Frequency of BCL6 Rearrangement at the Alternative Breakpoint Region (2009) (45)
- Role of the herbicide atrazine in the development of non-Hodgkin's lymphoma. (1993) (44)
- Richter's syndrome with different immunoglobulin light chain types. Molecular and cytogenetic features indicate a common clonal origin. (1992) (43)
- Non-Hodgkin's lymphomas of mantle zone origin. (1991) (43)
- Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma. (1999) (43)
- Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. (2016) (42)
- Peripheral T‐cell lymphoma A clinicopathologic study of a morphologically diverse entity (1985) (41)
- Castleman's disease of the leptomeninges. Report of three cases. (1988) (41)
- Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma (1990) (41)
- Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma. (1999) (40)
- Frequent occurrence of deletions in primary mediastinal B‐cell lymphoma (2007) (39)
- Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy. (1991) (39)
- Initial and subsequent cytogenetic studies in malignant lymphoma (1987) (39)
- T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases. (1995) (39)
- Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization. (2002) (39)
- Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. (2007) (38)
- Detection of malignant cells in histologically normal bone marrow using culture techniques. (1987) (38)
- Phenotype, genotype and clonality of Reed‐Sternberg cells in nodular sclerosis Hodgkin’s disease: results of a single‐cell study (1996) (38)
- Racial patterns of extranodal natural killer/T‐cell lymphoma, nasal type, in California: a population‐based study (2012) (37)
- Risk of diffuse large B‐cell lymphoma after solid organ transplantation in the United States (2014) (37)
- Mantle Cell Lymphoma With Plasma Cell Differentiation (2006) (37)
- Chromosomal abnormalities in indolent lymphoma. (1987) (37)
- Obesity and risk of non-Hodgkin lymphoma (United States) (2007) (36)
- Concurrent lymphocyte predominance Hodgkin's disease and T-cell lymphoma. A report of three cases. (1996) (36)
- Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodgkin's lymphoma in men. (2002) (36)
- The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade. (2002) (36)
- Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study. (1987) (35)
- Cell of origin fails to predict survival in patients with diffuse large B‐cell lymphoma treated with autologous hematopoietic stem cell transplantation (2012) (35)
- Aggressive natural killer cell lymphoma of the small intestine. (1995) (35)
- Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma (2009) (35)
- Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (34)
- Agricultural pesticide use and adenocarcinomas of the stomach and oesophagus (2004) (34)
- Soluble interleukin 2 receptors in patients with malignant lymphoma. (1988) (34)
- Di erent types of di use large b-cell lymphoma identi ed by gene expression pro ling (2000) (34)
- Sinus histiocytosis with massive lymphadenopathy: a spectrum of disease associated with immune dysfunction. (1991) (33)
- Pesticide exposures and the risk of multiple myeloma in men: An analysis of the North American Pooled Project (2016) (33)
- Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma. (1986) (32)
- Clinical Significance of the t(14;18) And BCL2 Overexpression in Follicular Large Cell Lymphoma (2000) (32)
- BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma. (2014) (32)
- Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study. (2007) (32)
- Acute myelofibrosis terminating as acute myeloblastic leukemia. (1980) (31)
- Epstein-Barr virus--associated lymphoproliferative lesions. (1988) (31)
- Characteristics and outcomes of diffuse large B‐cell lymphoma presenting in leukaemic phase (2012) (31)
- The tumor cells in nodular lymphocyte-predominant Hodgkin disease are clonally related to the large cell lymphoma occurring in the same individual. Direct demonstration by single cell analysis. (2001) (31)
- Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults. (2004) (31)
- Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project (2015) (30)
- HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. (2018) (30)
- Drinking Water and Dietary Sources of Nitrate and Nitrite and Risk of Glioma (2005) (29)
- Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC) (2017) (29)
- Hairy cell leukaemia: a heterogeneous disease? (2008) (29)
- Interstitial pneumonitis associated with azathioprine therapy. (1978) (28)
- Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium (2012) (28)
- ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients (2019) (28)
- Carcinogenicity of 1-(2-hydroxyethyl)-1-nitrosourea and 3-nitroso-2-oxazolidinone administered in drinking water to male MRC-Wistar rats: induction of bone, hematopoietic, intestinal, and liver tumors. (1987) (28)
- Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma. (2017) (28)
- Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM. (2011) (28)
- The antigen-presenting cell function of Reed-Sternberg cells. (1995) (27)
- Hyperplasia of mantle/marginal zone B cells with clear cytoplasm in peripheral lymph nodes. A clinicopathologic study of 35 cases. (2001) (27)
- Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro (2011) (27)
- Histologic grade does not predict prognosis in optimally treated, advanced‐stage nodular sclerosing Hodgkin's disease (1992) (27)
- Noncutaneous peripheral T‐cell lymphoma histologically resembling mycosis fungoides (1982) (27)
- Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14;18)-defined subtypes of non-Hodgkin's lymphoma. (2007) (27)
- Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma (2011) (27)
- Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice? (2015) (26)
- Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (26)
- Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma. (2013) (26)
- Dietary factors and risk of t(14;18)-defined subgroups of non-Hodgkin lymphoma (2008) (26)
- Epstein–Barr virus and Hodgkin’s lymphoma in Cairo, Egypt (2010) (26)
- Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. (1992) (25)
- Levels of detection of tumor cells in human bone marrow with or without prior culture. (1990) (25)
- Structural profiles of TP 53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study (2008) (25)
- Meat intake and risk of non-Hodgkin lymphoma (2012) (24)
- Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status (2017) (24)
- Phytanic acid and the risk of non-Hodgkin lymphoma. (2013) (24)
- Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome (2015) (24)
- Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin. (1990) (24)
- B-cell neoplasia. A conceptual understanding based on the normal humoral immune response. (1990) (24)
- Immunoblastic lymphadenopathy associated with methyldopa therapy. A case report (1978) (23)
- Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma: a Report of 21 Cases from the Nebraska Lymphoma Study Group (2004) (23)
- Lymphomas of follicles. Mantle cell and follicle center cell lymphomas. (1993) (22)
- Non‐Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non‐Hodgkin Lymphoma Classification Project (2016) (22)
- N-nitrosoatrazine : synthesis, kinetics of formation, and nuclear magnetic resonance spectra and other properties (1991) (22)
- Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. (2019) (21)
- Vaccination history and risk of non-hodgkin lymphoma: a population-based, case–control study (2009) (21)
- Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients (2005) (21)
- Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy. (2007) (21)
- CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity. (1991) (21)
- Pitfalls and major issues in the histologic diagnosis of peripheral T‐cell lymphomas: results of the central review of 573 cases from the T‐Cell Project, an international, cooperative study (2017) (20)
- Late relapse in patients with diffuse large B‐cell lymphoma (2010) (20)
- Medical history, lifestyle, family history, and occupational risk factors for adult acute lymphocytic leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (20)
- Prognostic significance of clinical and pathologic features in diffuse large B‐cell lymphoma (1993) (19)
- Systemic polyclonal B-immunoblastic proliferation with marked peripheral blood and bone marrow plasmacytosis. (1992) (19)
- Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implications. (2012) (19)
- Hereditary chronic lymphocytic leukemia: an extended family study and literature review. (2002) (18)
- Multicentric Angiofollicular Lymph Node Hyperplasia: Pathology of the Spleen (1988) (18)
- Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma. (1990) (18)
- Dietary patterns and the risk of non-Hodgkin lymphoma (2013) (18)
- Non-Hodgkin lymphoma risk and organophosphate and carbamate insecticide use in the north American pooled project (2019) (18)
- Identification and functional relevance of de novo DNA methylation in cancerous B‐cell populations (2010) (18)
- A Pooled Analysis of Alcohol Consumption and Risk of Multiple Myeloma in the International Multiple Myeloma Consortium (2013) (18)
- Targeting CD30 in Malignant Tissues: Challenges in Detection and Clinical Applications (2013) (18)
- Glyphosate use and associations with non-Hodgkin lymphoma major histological sub-types: findings from the North American Pooled Project. (2019) (17)
- Lymphomas with follicular and monocytoid B-cell components. Evidence for a common clonal origin from follicle center cells. (2000) (17)
- Cytogenetic abnormalities in noncutaneous peripheral T-cell lymphoma. (1986) (17)
- Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation. (1989) (17)
- Sex differences in the risk of multiple myeloma associated with agriculture. (1992) (17)
- Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines (2017) (16)
- Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma. (2013) (16)
- Immunophenotypic and genotypic characterization of lymphomatoid papulosis. (1992) (16)
- Effect of catechol and ethanol with and without methylamylnitrosamine on esophageal carcinogenesis in the rat. (1994) (16)
- Thrombotic thrombocytopenic purpura with C'3 vascular deposits: report of a case. (1977) (16)
- HTLV‐I Sequence in Lymphoproliferative Disorders (1993) (16)
- Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue. (1987) (16)
- The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. (2008) (15)
- Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists (2012) (15)
- Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group. (1994) (15)
- Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosis. (2012) (15)
- Risk factors for non‐Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population‐based case‐control study (2011) (14)
- Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage. (2007) (14)
- Prolymphocytic leukemia: Flow microfluorometric, immunologic, and cytogenetic observations (1980) (14)
- Legionnaires' disease among pneumonias in Iowa (FY 1972–1978) II. Epidemiologic and clinical features of 30 sporadic cases of L. pneumophila infection (1981) (14)
- A Pooled Analysis of Cigarette Smoking and Risk of Multiple Myeloma from the International Multiple Myeloma Consortium (2014) (14)
- Novel therapy for therapy‐resistant mantle cell lymphoma: Multipronged approach with targeting of hedgehog signaling (2012) (14)
- Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system (2011) (14)
- Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. (2011) (13)
- Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma. (1998) (13)
- BCL 2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma (2016) (13)
- Relationship between ambient ultraviolet radiation and Hodgkin lymphoma subtypes in the United States (2016) (13)
- Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status (2016) (13)
- Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohort (2016) (13)
- Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP (2020) (13)
- Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work). (2004) (12)
- Effects of 2,4,5-trichlorophenoxyacetic acid, pentachlorophenol, methylprednisolone, and Freund's adjuvant on 2-hydroxyethylnitrosourea carcinogenesis in MRC-Wistar rats. (1991) (12)
- Genetic and immunopathological findings in a lymphoma family. (1989) (12)
- Classification of non‐Hodgkin lymphoma in South‐eastern Europe: review of 632 cases from the international non‐Hodgkin lymphoma classification project (2015) (12)
- Prognostic factors influencing survival in patients with B‐cell small lymphocytic lymphoma (2004) (12)
- Cyclin D1 expression in peripheral T-cell lymphomas (2016) (12)
- Safety and efficacy of YM155 in diffuse large B-cell lymphoma (DLBCL). (2009) (12)
- Dietary nitrate and nitrite intake and risk of non-Hodgkin lymphoma (2013) (12)
- Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival (2008) (12)
- Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation. (2014) (11)
- Cytogenetic abnormalities in B-immunoblastic lymphoma. (1994) (11)
- Pesticide use and risk of Hodgkin lymphoma: results from the North American Pooled Project (NAPP) (2020) (11)
- Does asbestos exposure cause non-Hodgkin's lymphoma or related hematolymphoid cancers? A review of the epidemiologic literature. (2002) (11)
- Counterflow centrifugation apheresis for the collection of autologous peripheral blood stem cells from patients with malignancies: A comparison with a standard centrifugation apheresis procedure (1990) (10)
- Sun sensitivity, indoor tanning and B‐cell non‐Hodgkin lymphoma risk among Caucasian women in Los Angeles County (2017) (10)
- Multicentric Castleman's disease in a child with prominent thymic involvement: a case report and brief review of the literature. (1993) (10)
- The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component (2009) (9)
- Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults (2016) (9)
- Ortho-quinones of benzene and estrogens induce hyperproliferation of human peripheral blood mononuclear cells (2006) (9)
- Nerve growth factor receptor expression on dendritic reticulum cells in follicular lymphoid proliferations. (1991) (9)
- Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma? (2013) (9)
- Dietary intake of fruits and vegetables and overall survival in non-Hodgkin lymphoma (2013) (9)
- Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1. (2013) (9)
- 2-Hydroxyethylnitrosourea induction of B cell lymphoma in female Swiss mice. (1990) (8)
- CNOP for Diffuse Aggressive Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group Experience (2002) (8)
- Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients (2014) (8)
- Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline‐Based Therapy (2017) (8)
- Malakoplakia of bone. An unusual cause of pathologic fracture in an immunosuppressed patient. (1985) (8)
- The therapy of non-Hodgkin's lymphomas. Introduction and overview. (1991) (8)
- Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification (2015) (8)
- Peripheral T-cell lymphomas: diagnosis and treatment options. Proceedings from a live roundtable, August 17, 2011, Kauai, Hawaii. (2011) (8)
- Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: A case report (2012) (8)
- Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma (2021) (8)
- Non-Hodgkin's lymphomas of primary follicle/mantle zone origin. (1991) (8)
- Epidemiology and Pathology of T- and NK-Cell Lymphomas. (2018) (7)
- Stromal Tumor Microenvironment in Chronic Lymphocytic Leukemia: Regulation of Leukemic Progression (2013) (7)
- Non-Hodgkin's lymphoma and nitrate in drinking water (2000) (7)
- The relationship between lymphocyte nuclear morphology and cell cycle stage in lymphoid neoplasia (1981) (7)
- MALT) Lymphoma Lie within or near the Previously Undescribed Gene MALT1 in Chromosome 18 1 (1999) (7)
- Molecular Basis of Proliferation/Survival and Migration of CLL in Peripheral Blood, Bone Marrow and Lymph Nodes (2008) (7)
- The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population (2019) (7)
- A Review and Update with Perspective of Evidence that the Herbicide Glyphosate (Roundup) is a Cause of Non-Hodgkin Lymphoma. (2021) (7)
- Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase Mutations. (2019) (7)
- Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice (2022) (7)
- CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression (2014) (7)
- Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma. (2018) (7)
- DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T-cells in PTCL-NOS. (2022) (6)
- Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma. (2021) (6)
- Hodgkin's disease: a monoclonal lymphoproliferative disorder? (1995) (6)
- Mantle-zone lymphoma: another opinion. (1986) (6)
- Family with acute myelocytic leukemia, breast, ovarian, and gastrointestinal cancer. (2002) (6)
- Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics. (1995) (6)
- [Reproducibility and prognostic value of histopathological classifications of malignant lymphomas. Prolegomena for the 1st international classification proposed by WHO. Group of the non-Hodgkin's Malignant Lymphoma Classification Project]. (1998) (6)
- Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project (2015) (6)
- Specificity of Leu-M1 antibody for Reed-Sternberg cells. (1985) (6)
- Matrigel modulates a stem cell phenotype and promotes tumor formation in a mantle cell lymphoma cell line (2013) (5)
- CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT (2021) (5)
- New Genomic Model Integrating Clinical Factors and Gene Mutations to Predict Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP (2018) (5)
- Proliferative fraction and DNA content are lower in B-cell non-Hodgkin's lymphomas with the t(14;18). (1995) (5)
- Legionnaires' disease. (1980) (5)
- Immunoblastic lymphoma with abundant clear cytoplasm. A comparative study of B- and T-cell types. (1991) (5)
- Carcinogenicity tests of methyl-n-amylnitrosamine (MNAN) administered to newborn and adult rats and hamsters and adult mice and of 2-oxo-MNAN administered to adult rats. (1996) (5)
- International T-Cell Lymphoma Classification Project: Angioimmunoblastic T-Cell Lymphoma. (2006) (5)
- Insecticide use and risk of non‐Hodgkin lymphoma subtypes: A subset meta‐analysis of the North American Pooled Project (2020) (5)
- Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Clinicopathologic Study of 340 Cases from the International T-Cell Lymphoma Project. (2006) (4)
- Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma (2020) (4)
- Double Expressing (MYC/BCL2) and Double-Hit Diffuse Large B-Cell Lymphomas Have Inferior Survival Following Autologous Stem Cell Transplantation (2015) (4)
- Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma. (2004) (4)
- IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma (2015) (4)
- Chromosomal abnormalities in patients with non-cutaneous T-cell non-Hodgkin's lymphoma. The Nebraska Lymphoma Study Group. (1990) (4)
- Effect of addition of rituximab to CHOP on survival of patients in both the GCB and non-GCB subgroups of diffuse large B-cell lymphoma (2007) (4)
- Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells (2005) (4)
- Projeto de célula-T: estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo (2009) (4)
- Peripheral T-Cell Lymphoma-A Brief Review. (1990) (3)
- Expression of Immune Checkpoint Molecules PD1, PD-L1 and ICOS in Mycosis Fungoides and Sézary Syndrome: Association with Disease Stage and Clinical Outcome. (2022) (3)
- Expression of immune checkpoint molecules programmed death protein 1, programmed death‐ligand 1 and inducible T‐cell co‐stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome (2022) (3)
- Genetic counseling for DAPK1 mutation in a chronic lymphocytic leukemia family. (2008) (3)
- Basic References (3)
- Double-Hit and Double-Expressor Lymphomas Are Not Associated with an Adverse Outcome after Allogeneic Stem Cell Transplantation (2016) (3)
- RESPONSE: Re: Familial Multiple Myeloma: a Family Study and Review of the Literature (2002) (3)
- Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma (2014) (3)
- Is a duplication of 14q32 a new recurrent chromosomal alteration in B-cell non-Hodgkin lymphoma? (1999) (3)
- Progress in the classification of non-Hodgkin's lymphoma. (1993) (3)
- Blastic transformation of mantle cell lymphoma with B-lymphoblastic features (2019) (3)
- Epidemiology of extranodal lymphomas (2008) (3)
- Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma (2017) (3)
- 168 DRINKING WATER NITRATE AND NON-HODGKINʼS LYMPHOMA: A CASE-CONTROL STUDY IN NEBRASKA (1995) (3)
- Poor Survival Predicted by MDM2 Oncoprotein Expression in Diffuse Large B-Cell Lymphoma (DLBCL) with Wild-Type TP53 Gene (2008) (3)
- Preferential in-vitro growth and expansion of leukemic T lymphoblasts. (1988) (3)
- treatment outcome. The Nebraska Lymphoma Study Group lymphoma: associations with histology, clinical characteristics, and Chromosomal abnormalities in untreated patients with non-Hodgkin's (2011) (3)
- Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues (2014) (3)
- Potential Pathogenetic Role of Achromobacter (Alcaligenes) Xylosoxidans in Primary Extranodal Marginal Zone Lymphoma of the Lung (BALT-Lymphoma): Update of the Results of a Retrospective Analysis on Behalf of IELSG (2011) (3)
- Erratum to Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma [Cancer Cell 27, 516-532] April 13, 2015 10.1016/j.ccell.2015.04.014 (2015) (3)
- Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma? (2009) (3)
- Serum Ig abnormalities in mantle cell lymphoma [7] (multiple letters) (1997) (2)
- Molecular Determinants of Lymph Node Microenvironment Induced Host Immune Tolerance In CLL: Role for CAV1, PTPN6, and PKCβ In the Process (2010) (2)
- Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways (2016) (2)
- The Influence Of Lifestyle Factors On Tumor-Related Markers and The Microenvironment In Follicular Lymphoma (FL): Novel Interactions and Collective Impact On Survival (2013) (2)
- Elevated Serum Level of Fas Ligand Correlates With the Asymptomatic Stage of Human Immunodeficiency Virus Infection (1997) (2)
- Cyclin D1 Promotes Survival and Chemoresistance By Maintaining ATR and CHEK1 Signaling in TP53-Deficient Mantle Cell Lymphoma Cell Lines (2014) (2)
- Lymphoma Epidemiology Consortium (InterLymph) research from the Pathology Working Group of the International Proposed classification of lymphoid neoplasms for epidemiologic (2011) (2)
- Assessing Cancer Treatment Information Using Medicare and Hospital Discharge Data among Women with Non-Hodgkin Lymphoma in a Los Angeles County Case–Control Study (2020) (2)
- Validation of the double-hit gene expression signature (DLBCL90) in an independent cohort of patients with diffuse large B-cell lymphoma of germinal center origin. (2021) (2)
- Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma (2012) (2)
- Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status (2016) (2)
- NK-Cell Lymphoma Shares Strikingly Similar Molecular Features with a Distinct Set of γδ T-Cell Lymphoma and Identification of Aurora Kinase A Inhibitor as a Novel Therapeutic Agent. (2009) (2)
- Nodal marginal zone lymphoma. (2000) (2)
- Cytotoxic peripheral T cell lymphoma arising in a patient with nodular lymphocyte predominant Hodgkin lymphoma: a case report (2010) (2)
- Systemic ALK-Positive Anaplastic Large-Cell Lymphoma (ALCL): Final Analysis of an International, Individual Patient Data Study of 263 Adults (2017) (2)
- MUTATIONS IN AITL 1 IDH 2 R 172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma (2015) (2)
- 0409 The North American Pooled Project (NAPP): Pooled analyses of case-control studies of pesticides and agricultural exposures, lymphohematopoietic cancers and sarcoma (2014) (2)
- Diffuse Large B-Cell Lymphoma Subgroups Have Distinct Genetic Profiles that Influence Tumor Biology and Improve Gene Expression-Based Survival Prediction for the Lymphoma/Leukemia Molecular Profiling Project (2005) (2)
- Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin. (1993) (1)
- Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells (1997) (1)
- Follicular lymphoma polygenic risk score is associated with increased disease risk but improved overall survival among women in a population based case-control in Los Angeles County California. (2020) (1)
- #461 Cytogenetic abnormalities in tumors from children with non-Hodgkinʼs lymphoma (NHL) or Hodgkinʼs disease (HD): Nebraska Lymphoma Study Group experience (1999) (1)
- Primary Cutaneous Gamma-Delta T-Cell Lymphoma Mimicking anaplastic lymphoma kinase-1-Negative Anaplastic Large Cell Lymphoma: A Case Report (2021) (1)
- Sonic Hedgehog Signaling in Mantle Cell Lymphoma. (2006) (1)
- LMO2 Expression And The Hans Algorithm In Predicting Germinal Center Phenotype And Survival In Diffuse Large B-cell Lymphoma Treated With Rituximab (2009) (1)
- lymphoma by immunohistochemistry using a tissue microarray Confirmation of the molecular classification of diffuse large B-cell (2013) (1)
- Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP (2010) (1)
- Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraf fi n-Embedded Biopsies (2017) (1)
- Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma (2008) (1)
- Genomic Characterization of Diffuse Large B-Cell Lymphoma Transformation from Nodular Lymphocyte Predominant Hodgkin Lymphoma (2019) (1)
- Heat-Shock Protein Signature Is Associated with Refractory Chronic Lymphocytic Leukemia Cells From Different In Vivo Microenvironments, (2011) (1)
- Patients with Follicular Lymphoma, Grade 3, Have a Prolonged Relapse-Free Survival Following Aggressive Combination Chemotherapy. (2004) (1)
- Mutation Spectrum of Transformed Nodular Lymphocyte Predominant Hodgkin Lymphoma and Comparison with De Novo Diffuse Large B-Cell Lymphoma (2017) (1)
- Cyclin D1 Maintains Mantle Cell Lymphoma Through CDK4-Independent Regulation Of DNA Replicative Checkpoints (2013) (1)
- Distinctive Patterns of BCL6 Molecular Alterations in Different Subsets of Diffuse Large B-Cell Lymphoma and Their Functional Consequences. (2005) (1)
- The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL) (2010) (1)
- Risk of Acute Myeloid Leukemia Among Solid Organ Transplant Recipients (2011) (1)
- Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status (2014) (1)
- Survival Disparities in Patients with Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study (2008) (1)
- B-cell non-Hodgkin lymphoma (NHL) subtype risk associated with autoimmune conditions and polygenic risk scores (PRS). (2022) (1)
- Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group. (2007) (1)
- Follicular large cleaved cell (centrocytic) lymphoma: A distinctive but unrecognized variant of follicular lymphoma (2017) (1)
- Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project (2013) (1)
- Dendritic Cell-based Therapy for Mantle Cell Lymphoma (2007) (1)
- THE MUTATIONAL LANDSCAPE OF DOUBLE/TRIPLE‐HIT HIGH‐GRADE B‐CELL LYMPHOMA WITH BCL2 REARRANGEMENT (DH/TH‐ BCL2 ) – AN LLMPP PROJECT (2021) (1)
- Scientific category : LYMPHOID NEOPLASIA Title : A new biological prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma (2012) (1)
- The diversity of p53/p2l transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-Cell lymphoma (DLBCL) (2007) (1)
- Lymphoma with Features Intermediate Between DLBCL and Burkitt Lymphoma: Better Outcome with Intensive Chemotherapy Regimens (2011) (1)
- Anaplastic large cell lymphoma in human immunodeficiency virus‐infected people and solid organ transplant recipients (2020) (1)
- The Genomic Landscape of Plasmablastic Lymphoma (PBL) - an L.L.M.P.P. Project (2021) (1)
- Clinical prognostic factors are stronger predictors of outcome in non-Hodgkins lymphoma than pathological subtypes (1996) (1)
- Characterization and Novel Treatment for Therapy-Resistant Mantle Cell Lymphoma Isolated from Liver and Kidney (2008) (0)
- The diversity of p53/p21 transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-cell lymphoma (DLBCL) (2007) (0)
- Bone Marrow Transplantation for Peripheral T-cel l Lymphoma in Children and Adolescents (2003) (0)
- University of Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (0)
- Meat intake and risk of non-Hodgkin lymphoma (2012) (0)
- Neither Cell Of Origin Algorithms Or LMO2 Expression Predicts Survival In DLBCL Treated With Autologous Hematopoietic Stem Cell (HSC) Transplantation (2009) (0)
- Original Article Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemi- ologic study in the pre-rituximab era (2011) (0)
- Chapter 4 Molecular Diagnosis of Burkitt lymphoma (2019) (0)
- Predictor of survival Diffuse large B-cell lymphoma (2009) (0)
- The Impact of Cigarette Smoking On Overall Survival in Non-Hodgkin Lymphoma (2012) (0)
- The Aggressive Molecular Signature of Peripheral Blood Chronic Lymphocytic Leukemia (CLL) Cells From Patients with Bulky Lymphadenopathy Closely Resembles That of CLL Cells From Lymph Nodes (2011) (0)
- Polygenic Risk Score in Follicular Lymphoma Risk and Prognosis in a Population-Based Case-Control Study in Los Angeles County (2018) (0)
- Extranodal natural killer/T-cell lymphoma with paraneoplastic eosinophilic myositis (2020) (0)
- Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium (2012) (0)
- MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN‐FIXED, PARAFFIN‐EMBEDDED TISSUE SPECIMENS – AN LLMPP PROJECT (2017) (0)
- Upregulation of CD47 Expression in De Novo Diffuse Large B-Cell Lymphoma Is More Frequent in Activated B-Cell Type (2021) (0)
- Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma. (2023) (0)
- Abstract 1924: The paraproteins of patients with familial MGUS / multiple myeloma (MM) target family-specific antigens: Experience with paratarg-7 and paratarg-8 (2010) (0)
- Stromal Tumor Microenvironment in CLL: Regulation of Leukemic Progression (2012) (0)
- 25-year survival trends of patients with lymphoma by race/ethnicity as reported to the Nebraska Lymphoma Study Group (NLSG) (2008) (0)
- Targeting Conic Hedgehog-GLI Signaling for the Treatment of Mantle Cell Lymphoma (2007) (0)
- A Case-Control Study of Non-Hodgkin ' s Lymphoma and the Herbicide 2 , 4-Dichlorophenoxyacetic Acid ( 2 , 4-D ) in Eastern Nebraska Author ( s ) : (2011) (0)
- survival in mantle cell lymphoma mRNAs that are associated with increased proliferation rate and shorter Point mutations and genomic deletions in Cyclin D1 create stable truncated (2013) (0)
- Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma. (2012) (0)
- lymphoma and prognostication in angioimmunoblastic T-cell lymphoma Molecular signatures to improve diagnosis in peripheral T-cell (2013) (0)
- Influence of Lifestyle Factors On Expression of Tumor-Related Microenvironment T-Cells and Impact On Survival of Follicular Lymphoma (FL). (2012) (0)
- Transfusion History and Risk of Non-Hodgkin Lymphoma (NHL): an Interlymph Pooled Analysis (2014) (0)
- High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA. (2004) (0)
- Mutations in the Phosphoinositide 3-Kinase Pathway (PI3K) Are Associated with Poor Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP (2017) (0)
- Rapid development of HPV-mediated oropharyngeal squamous cell carcinoma in the setting of immune suppression following autologous stem cell transplantation for Hodgkin lymphoma (2017) (0)
- Environmental and genetic risk factors for t(14;18) subtypes of diffuse large B-cell lymphoma in a population-based, case-control study (2007) (0)
- Abstract 312: Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression and aggressiveness in non-Hodgkin's lymphoma (2011) (0)
- lineage disease and concurrent or subsequent large-cell lymphoma of B Clonal relationship between lymphocytic predominance Hodgkin's (2011) (0)
- AccuracyLymphoma into Molecular Subtypes with High A New Immunostain Algorithm Classifies Diffuse Large (2009) (0)
- Insecticide use is associated with increased risk of Hodgkin lymphoma: results from the North American Pooled Project (NAPP) (2016) (0)
- Therapeutic Effectiveness of Adaptive T-Cell Transfer for Minimal Residual Mantle Cell Lymphoma Following High Dose Therapy. (2007) (0)
- Abstract 4880: Characterization of genetic concordance between primary tumor cells, circulating tumor cells, and metastatic tumor cells from patients with prostate cancer (2015) (0)
- Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target (2016) (0)
- GLI1 Transcription Factor: A Potential Therapeutic Target in B-CLL. (2007) (0)
- Inmunoglobulin light chain enhancer hijacking activates CCND2 and CCND3 in cyclin D1-negative mantle cell lymphoma (2018) (0)
- SERUM IG ABNORMALITIES IN MANTLE CELL LYMPHOMA. AUTHORS' REPLY (1997) (0)
- Thrombotic thrombocytopenic purpura in a child with Alexander's disease. (1977) (0)
- Molecular Signatures to Improve Diagnosis, Prognostication and Identification of Oncogenic Pathways in Peripheral T and NK Cell Lymphoma. (2008) (0)
- Cytogenetic changes in follicular lymphoma with a diffuse large cell component (2005) (0)
- Significance of c-myc Rearrangements in Diffuse Large B-Cell Lymphoma. (2006) (0)
- Marginal Z one B -Cell L ymphoma: A C linical C omparison of N odal a nd M ucosa-Associate d L ymphoid T issue T ypes (1999) (0)
- PROGNOSTIC FACTORS AND IMPACT OF ETOPOSIDE IN ADULTS WITH SYSTEMIC ALK‐POSITIVE ANAPLASTIC LARGE‐CELL LYMPHOMA: A POOLED ANALYSIS OF SIX STUDIES (2017) (0)
- PRIMARY EXTRANODAL MARGINAL ZONE LYMPHOMA of the LUNG (BALT-LYMPHOMA): Results of a Retrospective Analysis on Behalf of IELSG (2010) (0)
- MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL. (2009) (0)
- Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis (2022) (0)
- germinal center B-cell gene expression profile The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a (2013) (0)
- Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma (2021) (0)
- The Impact of Histological Subtypes on Outcome in Patients with Mantle Cell Lymphoma Treated with or without Autologous Stem Cell Transplant. (2007) (0)
- Scientific category: Lymphoid neoplasia Title: Indolent T-cell lymphoproliferative disease of the gastrointestinal tract Authors: (2013) (0)
- An Evaluation Of Glyphosate Use And The Risks Of Non-Hodgkin Lymphoma Major Histological Sub-Types In The North American Pooled Project (Napp) (2015) (0)
- Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma. (2008) (0)
- MicroRNA Expression Profiling Identifies Molecular Diagnostic Signatures for Anaplastic Large Cell Lymphoma (2013) (0)
- Impact of age on outcome of autologous stem cell transplant for follicular and diffuse large B cell lymphoma (2004) (0)
- Organochlorine insecticide use and risk of non-Hodgkin lymphoma: findings from the North American Pooled Project (2016) (0)
- Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL). (2009) (0)
- LYMPHOID NEOPLASIA Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma (2010) (0)
- Classification of Hodgkin and non-Hodgkin lymphoma (2017) (0)
- Abstract B115: A pooled analysis of smoking and alcohol drinking and risk of multiple myeloma in the International Multiple Myeloma Consortium (2011) (0)
- Centrocytic lymphoma. (1993) (0)
- Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma (2013) (0)
- B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS (2022) (0)
- Clinical significance of cMYC Rearrangement in Diffuse Large B-cell Lymphoma (2011) (0)
- THE TOPOLOGY OF MYC REARRANGEMENTS IN DOUBLE‐HIT LYMPHOMA IS CONSTRAINED BY THE PRECEDING IGH ‐BCL2 REARRANGEMENT – AN LLMPP PROJECT (2021) (0)
- Analysis of gene expression in normal and malignant lymphocytes using the Lymphochip cDNA microarray (1999) (0)
- Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma (2021) (0)
- Results from a Phase 1 Study and Expanded Cohort of an Interrupted Dosing Schedule of the Aurora Kinase a Inhibitor MLN8237 Combined with Vorinostat in Lymphoid Malignancies (2015) (0)
- Mantle cell lymphoma: initial report from the North American Mantle Cell Lymphoma Consortium. (2020) (0)
- Abstract 1025: Risk of diffuse large B-cell lymphoma in solid organ transplant recipients (2012) (0)
- Pesticide use and risk of Hodgkin lymphoma: results from the North American Pooled Project (NAPP) (2020) (0)
- Rapid Communication Epstein-Barr Viral Genome in Lymph Nodes from Patients with Hodgkin's Disease May Not Be Specific to Reed-Sternberg Cells (2007) (0)
- Polycomb response element-binding sites in the MDR of CLL: Potential tumor suppressor regulation (2013) (0)
- Front & Back Matter (2013) (0)
- Burkitt Leukemia Involving Only the Bone Marrow Has a Better Prognosis Than Widespread Burkitt Lymphoma Involving the Bone Marrow in Adults (2014) (0)
- Non-Hodgkin Lymphoma Associated with Organophosphate and Carbamate Insecticides in the North American Pooled Project (2018) (0)
- Re: Familial multiple myeloma: A family study and review of the literature - Response (2002) (0)
- Brief report Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM (2011) (0)
- Genome-wide miRNAprofiling of mantle cell lymphoma reveals a distinctsubgroup with poor prognosis (2019) (0)
- PRE-binding sites in the MDR of CLL: Potential Tumor Suppressor Regulation (2013) (0)
- Impact of Bone Marrow Neuropathy on the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma (2013) (0)
- Outcome of Adolescent & Young Adult (AYA) Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (2012) (0)
- Abstract 2157: P73 isoforms regulate cellular survival and response to treatment in diffuse large B-cell lymphoma (2017) (0)
- Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype. (2007) (0)
- ‘ ‘ focus on . . . ’ ’ session : profiling and prognosis (2008) (0)
- Nebraska , United States Agricultural pesticide use and risk of glioma in and (2005) (0)
- Serial cytogenetic studies in malignant lymphoma (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Dennis D. Weisenburger?
Dennis D. Weisenburger is affiliated with the following schools:
